# Pierre Fabre Dermo Cosmetique clinical trials: 59 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 59 trials with Pierre Fabre Dermo Cosmetique as lead sponsor, 3 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Pierre Fabre Dermo Cosmetique: 59 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. The new rows each week by email, about 1 row a month: $19 a month. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email. The rows on this page are a sample.

Buy: https://specstream.ai/data/clinical-trials/company/pierre-fabre-dermo-cosmetique

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 59
- Recruiting or not yet: 3
- Read on: November 19, 2026

## Trials

The 25 newest of 59, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| September 24, 2026 | NCT07839897 | EFFICACY AND TOLERANCE OF AN EMOLLIENT CREAM IN SKIN OF COLOR | Pierre Fabre Dermo Cosmetique | Not applicable | Completed | Atopic Dermatitis (AD) | 59 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07839897) |
| September 14, 2026 | NCT07819071 | EFFICACY AND TOLERANCE OF AN EYELID BALM IN COMBINATION WITH TACROLIMUS 0.1% IN PATIENTS WITH EYELID ATOPIC DERMATITIS | Pierre Fabre Dermo Cosmetique | Not applicable | Completed | Atopic Dermatitis (AD) | 33 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07819071) |
| July 6, 2026 | NCT07685782 | A Randomized, Comparative Study to Evaluate the Effect of RL3014A-DP0421 Mouthwash on the Oral Microbial Composition | Pierre Fabre Dermo Cosmetique | Not applicable | Completed | Healthy | 109 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07685782) |
| May 11, 2026 | NCT07577921 | Evaluation of the Efficacy of a Cosmetic Care in Subjects With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments | Pierre Fabre Dermo Cosmetique | Observational | Completed | Atopic Dermatitis | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07577921) |
| May 8, 2026 | NCT07576023 | A 4-weeks Comparative Study of Cosmetic Product Versus Standard Medical Care in Subjects With Seborrheic Dermatitis | Pierre Fabre Dermo Cosmetique | Not applicable | Completed | Seborrheic Dermatitis | 90 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07576023) |
| May 8, 2026 | NCT07575997 | Comparison Between Different Interdental Brushes in Adults With Periodontal Disease. | Pierre Fabre Dermo Cosmetique | Not applicable | Recruiting | Periodontal Disease | 88 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07575997) |
| January 14, 2026 | NCT07341659 | Efficacy of Cosmetic Product RV3278B-OS0386 in the Maintenance Phase After Oral Isotretinoin Treatment of Adults Subjects With Facial Acne. | Pierre Fabre Dermo Cosmetique | Not applicable | Active not recruiting | Acne | 102 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07341659) |
| December 9, 2025 | NCT07271628 | Evaluation of the Moisturizing Effect of Study Product AV0018B and the Persistence of This Effect After Repeated Applications, Compared to... | Pierre Fabre Dermo Cosmetique | Observational | Completed | Dry Skin | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07271628) |
| October 6, 2025 | NCT07208227 | In-use Tolerance and Efficacy Study Under Dermatological and Ophthalmological Controls - Face Cream, RV4983A - LA3365 | Pierre Fabre Dermo Cosmetique | Observational | Completed | Healthy, Sensitive Skin, Deep Wrinkles | 44 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07208227) |
| September 26, 2025 | NCT07194421 | In-Use Tolerance & Efficacy Study Under Dermatological Control of Sunscreen in Adults With Atopic Dermatitis Skin | Pierre Fabre Dermo Cosmetique | Observational | Completed | Atopic Dermatitis (AD), SCORAD Index(15-25) | 42 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07194421) |
| September 26, 2025 | NCT07194408 | In-Use Tolerance Study Under Dermatological and Pediatric Controls of Sunscreen in Children With Atopic Dermatitis | Pierre Fabre Dermo Cosmetique | Observational | Completed | Atopic Dermatitis (AD), SCORAD Index (15-25) | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07194408) |
| September 10, 2025 | NCT07166497 | Evaluation of the Effect of the Product RV4660C CY0203 on Clinical, Biometrological and Biological Parameters in Adults With Mild to... | Pierre Fabre Dermo Cosmetique | Observational | Completed | Mild to Moderate Atopic Dermatitis | 21 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07166497) |
| September 10, 2025 | NCT07166484 | Assessment of the Effect of the Product RV2666C Formula LA2984 Compared to an Untreated Area With an Epidermally Ablated Skin Model... | Pierre Fabre Dermo Cosmetique | Observational | Completed | Healthy | 22 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07166484) |
| June 13, 2025 | NCT07020507 | Exploratory Study to Evaluate the Efficacy of the Cosmetic Product RV3895A on Re-epidermised Scars Following Burns and Surgical Stitches in... | Pierre Fabre Dermo Cosmetique | Observational | Terminated | Skin Scars, Post-burn Scars, Post-surgical-stitches Scars | 35 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07020507) |
| June 12, 2025 | NCT07017348 | Assessment of Clinical, Biological and Biometrological Parameters in Adults Subjects With Atopic Dermatitis | Pierre Fabre Dermo Cosmetique | Not applicable | Completed | Atopic Dermatitis, Healthy | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07017348) |
| June 10, 2025 | NCT07014007 | Tolerance and Efficacy Open-label Study With RV4421B, in Various Populations With Atopic Dermatitis for 12 Weeks | Pierre Fabre Dermo Cosmetique | Not applicable | Recruiting | Atopic Dermatitis | 105 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT07014007) |
| May 30, 2025 | NCT06997718 | Evaluation of the Effects of the Product RV5075A-MF6793 in Diabetic Patients Presenting Foot Xerosis and Superficial Fissures, an... | Pierre Fabre Dermo Cosmetique | Not applicable | Completed | Diabetic Foot Xerosis | 62 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06997718) |
| May 21, 2025 | NCT06983561 | Description of the Population With Moderate to Severe Atopic Dermatitis, Treated by Systemic Treatments and Needs Regarding Emollients | Pierre Fabre Dermo Cosmetique | Observational | Completed | Atopic Dermatitis | 80 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06983561) |
| April 24, 2025 | NCT06942403 | In-use Tolerance and Efficacy Study Under Dermatological Control of an Anti-aging Cream (Split Face) Post Facial Superficial Rejuvenation... | Pierre Fabre Dermo Cosmetique | Not applicable | Completed | Healthy | 66 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06942403) |
| March 3, 2025 | NCT06854432 | Assessment of Biological and Biometrological Parameters in Adult Subjects with Androgenetic Alopecia | Pierre Fabre Dermo Cosmetique | Not applicable | Terminated | Alopecia, Androgenetic, Healthy | 46 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06854432) |
| February 24, 2025 | NCT06841393 | Assessment of Biological, Biometrological Parameters and Consumer Needs in Adult Subjects with Acne | Pierre Fabre Dermo Cosmetique | Not applicable | Terminated | Acne, Healthy | 50 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06841393) |
| February 13, 2025 | NCT06824870 | Exploratory Study Evaluating the Effects of Dermo-cosmetic RV5026B Applied for 2 Months in Adults With Erythrocouperosis | Pierre Fabre Dermo Cosmetique | Not applicable | Terminated | Erythrocouperose Associated With Pityriasis Folliculorum of the Face | 28 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06824870) |
| January 30, 2025 | NCT06800755 | Evaluation of the Efficacy and Tolerance of the Medical Device RL3020-DP0364 in Adult Population With Stable Mild Plaque Psoriasis, Dry... | Pierre Fabre Dermo Cosmetique | Not applicable | Completed | Psoriasis, Pruritus, Dry Skin | 40 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06800755) |
| January 8, 2025 | NCT06763939 | Evaluation of the Efficacy of a Dermocosmetic Product RT00401-GO0046 on Atopic Dermititis Severity in Subjects With Mild Atopic Dermatitis... | Pierre Fabre Dermo Cosmetique | Observational | Completed | Atopic Dermatitis | 32 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06763939) |
| December 4, 2024 | NCT06716398 | A Comparative Study of Cosmetic Product in Subjects With Facial Acne During an Associated-treatment Phase Followed by a Maintenance Phase | Pierre Fabre Dermo Cosmetique | Not applicable | Recruiting | Acne | 60 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06716398) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 3 | 1 |
| Phase 4 | 1 |
| Not applicable | 34 |
| Observational | 23 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 44 |
| Terminated | 6 |
| Unknown | 4 |
| Recruiting | 3 |
| Active not recruiting | 1 |
| Withdrawn | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| Dermatitis, Atopic | 12 |
| Acne Vulgaris | 9 |
| Pruritus | 4 |
| Dermatitis, Seborrheic | 3 |
| Facies | 2 |
| Psoriasis | 2 |
| Eczema | 2 |
| Dermatitis | 2 |
| Hypersensitivity | 2 |
| Alopecia | 2 |
| Onychomycosis | 2 |
| Lentigo | 1 |
| Hyperpigmentation | 1 |
| Vitiligo | 1 |
| Cone-Rod Dystrophy, X-Linked, 3 | 1 |
| Erythema | 1 |
| Paresthesia | 1 |
| Periodontal Diseases | 1 |
| Rosacea | 1 |
| Wounds and Injuries | 1 |
| Dermatomycoses | 1 |
| Infections | 1 |
| Mycoses | 1 |
| Nail Diseases | 1 |
| Cellulitis | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [Tires manufacturers in the United States](https://specstream.ai/data/businesses/tires-manufacturers/united-states)
- [Leather products manufacturers in the United States](https://specstream.ai/data/businesses/leather-products-manufacturers/united-states)
- [Chiropractic clinics in the United States](https://specstream.ai/data/businesses/chiropractic-clinics/united-states)
- [Spine surgery practices in the United States](https://specstream.ai/data/businesses/spine-surgery-practices/united-states)
- [Insulation contractors in the United States](https://specstream.ai/data/businesses/insulation-contractors/united-states)
- [Building contractors in the United States](https://specstream.ai/data/businesses/building-contractors/united-states)
